当前位置:主页 > 医学论文 > 五官科论文 >

磷酸肌酸钠治疗Leber遗传性视神经病变的初步临床观察

发布时间:2019-04-20 18:04
【摘要】:目的观察磷酸肌酸钠治疗Leber遗传性视神经病变(LHON)的有效性。设计回顾性病例系列。研究对象2014年1月至2016年1月武汉同济医院眼科确诊的LHON患者19例。根据患者是否同意住院治疗分为两组,10例住院者为治疗组,9例门诊观察未做治疗者为对照组。方法对治疗组的10例LHON患者进行磷酸肌酸钠治疗,每日2次,每次1 g,加入250 ml生理盐水中静脉滴注,共7天。观察患者治疗前后的视力、视野变化。对照组的9例患者未治疗。19例患者随访观察1年。主要指标视力、视野。结果与治疗前视力相比,治疗7天后,治疗组患者中3例患者(1号右眼,6号右眼,7号左眼)视力提高,分别提高0.3 LogMAR、0.4 LogMAR、0.7 LogMAR。随访1年后,1号右眼视力下降,6号和7号视力无变化。3例患者中14484位点突变的有2例(6号和7号),11778位点突变的有1例(1号);另外7例视力无显著改变。10例患者的视野(VFI和MD)治疗前后无显著差异(P=0.167,0.20)。未经治疗的9例患者随访观察1年,视力无变化。结论磷酸肌酸钠治疗Leber遗传性视神经病变或许对14484位点突变患者的视力提高或稳定有一定的疗效。
[Abstract]:Objective to observe the efficacy of sodium phosphate in the treatment of Leber hereditary optic neuropathy (LHON). Design retrospective case series. From January 2014 to January 2016, 19 LHON patients were diagnosed in Wuhan Tongji Hospital. The patients were divided into two groups according to whether they agreed to be treated in hospital, 10 inpatients as treatment group and 9 out-patient as control group. Methods Ten LHON patients in the treatment group were treated with sodium phosphate for 7 days, twice a day, 1 g each time, injected intravenously with 250 ml normal saline for 7 days. The visual acuity and visual field before and after treatment were observed. In the control group, 9 patients were untreated and 19 patients were followed up for 1 year. Main outcome measures: visual acuity, visual field. Results after 7 days of treatment, the visual acuity of 3 patients (right eye No. 1, right eye No. 6, left eye No. 7) in the treatment group was improved by 0.3 LogMAR,0.4 LogMAR,0.7 LogMAR. respectively. After 1-year follow-up, the visual acuity of No. 1 right eye decreased, and the visual acuity of No. 6 and No. 7 did not change. Of the 3 patients, 2 (6 and 7) had 14484 point mutation and 1 (1) had 11778 point mutation. The visual field (VFI) and the visual field (MD) of 10 patients had no significant difference before and after treatment (P < 0. 167, 0. 20). There was no change in visual acuity in 9 patients who had not been treated for 1 year. Conclusion the treatment of Leber's hereditary optic neuropathy with sodium phosphate may be effective in improving or stabilizing the visual acuity of the patients with point mutation at position 14484.
【作者单位】: 华中科技大学同济医学院附属同济医院眼科;鄂州市第五医院药剂科;鄂州市第五医院超声科;
【分类号】:R774.6

【相似文献】

相关期刊论文 前10条

1 梁敏;瞿佳;周翔天;管敏鑫;;线粒体功能缺陷在遗传性视神经病变发病机制中的作用[J];眼视光学杂志;2009年03期

2 王相贤;Leber's视神经病[J];眼科新进展;1982年03期

3 ;遗传性视神经病变突变可致高血压病[J];广西科学院学报;2012年03期

4 孟晓峰;陈辉;杜培洁;宋国英;金学民;李晓雯;;Leber遗传性视神经病遗传早发现象观察[J];郑州大学学报(医学版);2007年03期

5 许倩倩;刘铁城;;Leber遗传性视神经病变发病机制的研究进展[J];军医进修学院学报;2012年06期

6 朱斌,张丽珊,黄鹰,童绎,高静娟;核DNA对Leber遗传性视神经病的影响[J];中国优生与遗传杂志;1997年06期

7 王淑芬,郭秀瑾,赵瑞芝;Leber遗传性视神经病二家系[J];中国实用眼科杂志;2003年12期

8 韩桂梅;;Leber遗传性视神经病一家系[J];眼科新进展;2006年06期

9 韦企平,张丽霞,杨薇,路明;Leber遗传性视神经病变24例临床分析[J];中国实用眼科杂志;2000年09期

10 林玲,郑志z,

本文编号:2461828


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/wuguanyixuelunwen/2461828.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户3f677***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com